ObesityNCT06371105
Aquatic_Training in Obese Women
A study testing 10-week water-based aerobic training in people with Obesity, run by University of Taipei at 1 site in Taiwan.
Trial summary
This study aims to assess the effects of 10-week water-based aerobic training (thrice a week) on anthropometrics, biochemicals, cardiovascular parameters, and explosive strength in young overweight and obese women. Read more about this study
- Who is it for?
- Ages 29 to 35 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Obesity
- What is being tested?
- 10-week water-based aerobic training
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 31 participants
- Where
- 1 siteTaiwan
- Study dates
- 2 Jan 2019to 30 Mar 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 29 to 35 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Age between 20 and 35 years
- Sedentary lifestyle within six month
- Not using drugs or other therapy for obesity.
Who cannot join
- BMI below 25.0 and over 34.9 kg.m-2
- having any infectious or skin diseases
Trial locations and contacts
1 site in 1 country.
Taiwan1 site
Department of Exercise and Health Sciences, University of Taipei
Taipei, 11153
About this study
Official title: Effect of Water-based Aerobic Training on Anthropometric, Biochemical, Cardiovascular, and Explosive Strength Parameters in Young Overweight and Obese Women
This study aims to assess the effects of 10-week water-based aerobic training (thrice a week) on anthropometrics, biochemicals, cardiovascular parameters, and explosive strength in young overweight and obese women. The findings indicate that water-based aerobic training could be a useful program to enhance body composition, biochemical, cardiovascular, and explosive strength parameters in young overweight and obese women compared to inactive persons
Read the detailed description
This study is based on a randomized controlled trial with a pre-to-post testing design, twenty-seven young overweight and obese women were assigned to training group (a water-based aerobic training) or control group (maintaining their usual activities during the studying period. For each training session, water activities were implemented for 50 min which included warm-up (10 min), main activities (30 min), and cool-down (10 min). The swimming pool where the intervention took part was 1.50 m deep of water. The pre- and post-intervention participants were assessed for their anthropometrics, biochemicals (fasting glycemia, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol and triglyceride (TG)), resting blood pressure, and resting heart rate, and explosive strength of upper (countermovement jump and squat jump) and lower limbs (a seated medicine ball throw test).
- Conditions
- Obesity
- Being tested
- 10-week water-based aerobic training
- Keywords
- aquatic training, body composition, lipid profile, obesity management, physical fitness testing, resting heart rate
- Medical subject headings
- Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
10-week water-based aerobic trainingOther
The water-based aerobic program was adopted from the protocol previously used by Costa et al. (2018, 2020). This training program was carried out thrice a week over 2 non-consecutive days 48 hours apart for 10 weeks according to ACSM guidelines
| Study group | Role | What they receive |
|---|---|---|
| Training group | Experimental | Performing a 10-week water-based aerobic training (thrice/week) Receives: Other: 10-week water-based aerobic training |
| Control group | No intervention | Maintaining their usual activities during the interventional period |
What is being measured
The primary outcome is the main question the study is designed to answer.
fasting glycemia in millimoles per liter
baseline blood sample
Measured: 3 days before the 10-week interventional period
total cholesterol in millimoles per liter
baseline blood sample
Measured: 3 days before the 10-week interventional period
high-density lipoprotein cholesterol in millimoles per liter
baseline blood samplelipoprotein cholesterol, and triglyceride concentrations
Measured: 3 days before the 10-week interventional period
low-density lipoprotein cholesterol in millimoles per liter
baseline blood sample
Measured: 3 days before the 10-week interventional period
triglyceride concentrations in millimoles per liter
baseline blood sample
Measured: 3 days before the 10-week interventional period
systolic blood pressure in millimeters of mercury
baseline blood sample
Measured: 3 days before the 10-week interventional period
diastolic blood pressure in millimeters of mercury
baseline blood sample
Measured: 3 days before the 10-week interventional period
heart rate in beat per minute
baseline blood sample
Measured: 3 days before the 10-week interventional period
fasting glycemia in millimoles per liter
post-training blood sample
Measured: one day after the 10-week interventional period
total cholesterol in millimoles per liter
post-training blood sample
Measured: one day after the 10-week interventional period
high-density lipoprotein cholesterol in millimoles per liter
post-training blood sample
Measured: one day after the 10-week interventional period
low-density lipoprotein cholesterol in millimoles per liter
post-training blood sample
Measured: one day after the 10-week interventional period
triglyceride concentrations in millimoles per liter
post-training blood sample
Measured: one day after the 10-week interventional period
systolic blood pressure in millimeters of mercury
post-training blood sample
Measured: one day after the 10-week interventional period
diastolic blood pressure in millimeters of mercury
post-training blood sample
Measured: one day after the 10-week interventional period
heart rate in beat per minute
post-training blood sample
Measured: one day after the 10-week interventional period
Secondary outcomes (6)
countermovement jump in centimetres
baseline lower limbs power test
Measured: 3 days before the 10-week interventional period
squat jump in centimeters
baseline lower limbs power test
Measured: 3 days before the 10-week interventional period
chest 3-kg medicine ball throw in meters
baseline upper limbs power test
Measured: 3 days before the 10-week interventional period
countermovement jump in centimetres
post-training lower limbs power test
Measured: one day after the 10-week interventional period
squat jump in centimeters
post-training lower limbs power test
Measured: one day after the 10-week interventional period
chest 3-kg medicine ball throw in meters
post-training upper limbs power test
Measured: one day after the 10-week interventional period
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Apr 2024
- Study start2 Jan 2019
- Primary completion30 Mar 2019
- Study completion30 Mar 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 31 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Taipei
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, YUNG-SHENG CHEN, University of Taipei
- Investigators
- Yung-Sheng Chen, Ph.D., Study director, Department of Exercise and Health Sciences, University of Taipei
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06371105
- Sponsor's protocol ID
- 014_2018
- Status last verified
- Apr 2024
- First submitted
- 28 Mar 2024
- Last updated
- 17 Apr 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Water-based Aerobic Training on Anthropometric, Biochemical, Cardiovascular, and Explosive Strength Parameters in Young Overweight and Obese Women
- ClinicalTrials.gov ID
- NCT06371105
- Acronym / sponsor ID
- 014_2018
- Conditions
- Obesity
- Keywords
- aquatic training, body composition, lipid profile, obesity management, physical fitness testing, resting heart rate
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 31 participants (actual)
- Lead sponsor
- University of TaipeiUniversity, hospital or other
- Study start
- 2 Jan 2019 (actual)
- Primary completion
- 30 Mar 2019 (actual)
- Study completion
- 30 Mar 2019 (actual)
- First posted
- 17 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to assess the effects of 10-week water-based aerobic training (thrice a week) on anthropometrics, biochemicals, cardiovascular parameters, and explosive strength in young overweight and obese women. The findings indicate that water-based aerobic training could be a useful program to enhance body composition, biochemical, cardiovascular, and explosive strength parameters in young overweight and obese women compared to inactive persons
Detailed description
This study is based on a randomized controlled trial with a pre-to-post testing design, twenty-seven young overweight and obese women were assigned to training group (a water-based aerobic training) or control group (maintaining their usual activities during the studying period. For each training session, water activities were implemented for 50 min which included warm-up (10 min), main activities (30 min), and cool-down (10 min). The swimming pool where the intervention took part was 1.50 m deep of water. The pre- and post-intervention participants were assessed for their anthropometrics, biochemicals (fasting glycemia, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol and triglyceride (TG)), resting blood pressure, and resting heart rate, and explosive strength of upper (countermovement jump and squat jump) and lower limbs (a seated medicine ball throw test).
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Training group | Experimental | Other: 10-week water-based aerobic trainingPerforming a 10-week water-based aerobic training (thrice/week) |
| Control group | No intervention | –Maintaining their usual activities during the interventional period |
Who may qualify
- Ages
- 29 to 35 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Age between 20 and 35 years
- Sedentary lifestyle within six month
- Not using drugs or other therapy for obesity.
Key exclusion criteria (2 listed)
- BMI below 25.0 and over 34.9 kg.m-2
- having any infectious or skin diseases
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 10-week water-based aerobic trainingThe water-based aerobic program was adopted from the protocol previously used by Costa et al. (2018, 2020). This training program was carried out thrice a week over 2 non-consecutive days 48 hours apart for 10 weeks according to ACSM guidelines | Other | Training group |
Primary outcome
fasting glycemia in millimoles per liter
Time frame: 3 days before the 10-week interventional period
baseline blood sample
total cholesterol in millimoles per liter
Time frame: 3 days before the 10-week interventional period
baseline blood sample
high-density lipoprotein cholesterol in millimoles per liter
Time frame: 3 days before the 10-week interventional period
baseline blood samplelipoprotein cholesterol, and triglyceride concentrations
low-density lipoprotein cholesterol in millimoles per liter
Time frame: 3 days before the 10-week interventional period
baseline blood sample
triglyceride concentrations in millimoles per liter
Time frame: 3 days before the 10-week interventional period
baseline blood sample
systolic blood pressure in millimeters of mercury
Time frame: 3 days before the 10-week interventional period
baseline blood sample
diastolic blood pressure in millimeters of mercury
Time frame: 3 days before the 10-week interventional period
baseline blood sample
heart rate in beat per minute
Time frame: 3 days before the 10-week interventional period
baseline blood sample
fasting glycemia in millimoles per liter
Time frame: one day after the 10-week interventional period
post-training blood sample
total cholesterol in millimoles per liter
Time frame: one day after the 10-week interventional period
post-training blood sample
high-density lipoprotein cholesterol in millimoles per liter
Time frame: one day after the 10-week interventional period
post-training blood sample
low-density lipoprotein cholesterol in millimoles per liter
Time frame: one day after the 10-week interventional period
post-training blood sample
triglyceride concentrations in millimoles per liter
Time frame: one day after the 10-week interventional period
post-training blood sample
systolic blood pressure in millimeters of mercury
Time frame: one day after the 10-week interventional period
post-training blood sample
diastolic blood pressure in millimeters of mercury
Time frame: one day after the 10-week interventional period
post-training blood sample
heart rate in beat per minute
Time frame: one day after the 10-week interventional period
post-training blood sample
6 secondary outcomes
countermovement jump in centimetres
Time frame: 3 days before the 10-week interventional period
squat jump in centimeters
Time frame: 3 days before the 10-week interventional period
chest 3-kg medicine ball throw in meters
Time frame: 3 days before the 10-week interventional period
countermovement jump in centimetres
Time frame: one day after the 10-week interventional period
squat jump in centimeters
Time frame: one day after the 10-week interventional period
chest 3-kg medicine ball throw in meters
Time frame: one day after the 10-week interventional period
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Apr 2024.
- Individual participant dataSharing planned: No
Related trials for Obesity
Not yet recruiting
Negative Pressure Wound Therapy Devices in Total Knee Arthroplasty
Wound Surgical, Diabetes
RecruitingObservational study
Asprosin and miRNA Expression in Young Women With Metabolic Syndrome
Metabolic Syndrome, Insulin Resistance
RecruitingObservational study
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Metabolic Disease, Obesity
Recruiting
Confident Moves Intervention Efficacy Trial: Obesity Care Settings
Obesity, Overweight
Not yet recruiting
Stearic Acid and Endothelial Function
Healthy Middle-aged Subjects, Obesity & Overweight
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yung-Sheng Chen, Ph.D. study director
Department of Exercise and Health Sciences, University of Taipei
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing 10-week water-based aerobic training in people with Obesity, run by University of Taipei at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
fasting glycemia in millimoles per liter (time frame: 3 days before the 10-week interventional period). The study lists 16 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2024.